TriSalus Life Sciences (TLSI) Cash from Operations Growth (3y) (2024 - 2026)
TriSalus Life Sciences (TLSI) Cash from Operations Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn | 50.11% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | -14.75% |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 0.50% |
| 10 | TriSalus Life Sciences | 224.71 Mn | 168.16 Mn | 7.67 Mn | 14.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.87% |
| Dec 31, 2025 | 33.14% |
| Sep 30, 2025 | 45.47% |
| Jun 30, 2025 | -119.02% |
| Mar 31, 2025 | -119.41% |
| Dec 31, 2024 | -103.13% |
| Sep 30, 2024 | -209.71% |
| Jun 30, 2024 | -202.23% |
| Mar 31, 2024 | -275.14% |